Atrás
76
Rango del Día
$60.92
$63.99
Rango de 52 Semanas
$15.40
$68.39
Volumen
224,165
Promedio 50D / 200D
$53.61
/
$36.18
Cierre Anterior
$62.72
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -136.9 | 0.3 |
| P/B | 48.7 | 2.9 |
| ROE % | -24.5 | 3.7 |
| Net Margin % | -5.6 | 3.8 |
| Rev Growth 5Y % | 38.8 | 10.0 |
| D/E | 0.4 | 0.2 |
Precio Objetivo de Analistas
Hold
$73.71
+17.0%
Low: $50.00
High: $140.00
EPS Futuro
-$3.94
Ingresos Est.
110 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.06
$1.26 – $8.34
|
490 M | 6 |
| FY2029 |
$0.20
$0.06 – $0.41
|
320 M | 6 |
| FY2028 |
-$0.34
-$2.49 – $1.73
|
270 M | 8 |
Puntos Clave
Revenue grew 38.82% annually over 5 years — strong growth
Debt/Equity of 0.38 — conservative balance sheet
Generating 19.61M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 118.19%
Capital efficient — spends only 0.04% of revenue on capex
ROIC of 69.99% — excellent capital efficiency
Crecimiento
Revenue Growth (5Y)
38.82%
Revenue (1Y)157.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-24.49%
ROIC69.99%
Net Margin-5.64%
Op. Margin20.42%
Seguridad
Debt / Equity
0.38
Current Ratio9.07
Interest Coverage0.60
Valoración
P/E Ratio
-136.92
P/B Ratio48.69
EV/EBITDA33.15
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 157.01% | Revenue Growth (3Y) | 269.78% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 234.60M | Net Income (TTM) | -13.23M |
| ROE | -24.49% | ROA | -3.63% |
| Gross Margin | 98.97% | Operating Margin | 20.42% |
| Net Margin | -5.64% | Free Cash Flow (TTM) | 19.61M |
| ROIC | 69.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.38 | Current Ratio | 9.07 |
| Interest Coverage | 0.60 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -136.92 | P/B Ratio | 48.69 |
| P/S Ratio | 7.72 | PEG Ratio | 1.12 |
| EV/EBITDA | 33.15 | Dividend Yield | 0.00% |
| Market Cap | 1.81B | Enterprise Value | 1.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 234.60M | 91.28M | 17.16M | 10.29M | 63.18M |
| Net Income | -13.23M | -145.23M | -163.62M | -128.72M | -57.80M |
| EPS (Diluted) | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 |
| Gross Profit | 232.18M | -72.56M | -115.13M | -78.51M | -35.32M |
| Operating Income | 47.90M | -114.95M | -164.41M | -115.15M | -56.81M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 364.40M | 483.83M | 452.39M | 610.38M | 643.07M |
| Total Liabilities | 327.19M | 412.97M | 364.29M | 348.28M | 286.64M |
| Shareholders' Equity | 37.21M | 70.87M | 88.10M | 262.10M | 356.43M |
| Total Debt | 14.11M | 369.46M | 17.81M | 19.45M | 20.96M |
| Cash & Equivalents | 238.20M | 123.08M | 35.97M | 71.31M | 495.73M |
| Current Assets | 350.25M | 431.88M | 406.84M | 447.21M | 553.88M |
| Current Liabilities | 38.63M | 45.43M | 37.44M | 26.05M | 16.10M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#8 of 146
Actividad Reciente
Entró
Full Throttle
Mar 24, 2026